MannKind(MNKD) - 2024 Q2 - Quarterly Results

EXHIBIT 99.1 mannkind MANNKIND CORPORATION REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS: PROVIDES CLINICAL DEVELOPMENT UPDATE Conference Call to Begin Today at 9:00 a.m. (ET) • 2Q 2024 Total revenues of $72M; +49% vs. 2Q 2023 • YTD 2024 Total revenues of $139M; +55% vs. YTD 2023 • YTD 2024 Net income of $9 million; Non-GAAP net income of $29 million • Advances two orphan lung programs to human studies o MNKD-101 Phase 3 clinical trial activities initiated o MNKD-201 Phase 1 clinical trial on schedule to re ...